Mailed orders double liver cancer screening rates
Liver cancer screening among patients with cirrhosis almost doubled when they were mailed a signed order from their specialist, according to a new study from the Perelman School of Medicine at the...
View ArticlePenn researchers uncover unexpected molecular pattern in FXS
Penn researchers uncover severe DNA misfolding and the silencing of genes are related to synaptic and connective tissue tied to Fragile X Syndrome.
View ArticleAI Tool Brings Precision Pathology for Cancer Into Focus
Penn Medicine researchers developed an artificial intelligence tool to quickly analyze gene activities in medical images and provide single-cell insight into diseases in tissues and tissue...
View ArticleYAP and TAZ: Protein partners key for fetal bone development
A pair of proteins, YAP and TAZ, has been identified as conductors of bone development in the womb and could provide insight into genetic diseases such as osteogenesis imperfecta, known commonly as...
View ArticleNew Program for Psoriasis Patients Highlights Cardiovascular Risk
Almost 30 percent of the patients in a pilot program for those with psoriasis that was devised by researchers from the Perelman School of Medicine were identified as having undiagnosed, elevated risk...
View ArticleOut-of-pocket cost hike could put HIV medications out of reach
Even modest increases in out-of-pocket costs for HIV prevention drugs could double rate at which prescriptions go unfilled.
View ArticleAnalysis: COVID Vaccine Strongly Effective in Young People
Children and adolescents who received one of the main COVID-19 vaccines were significantly protected from the illness and showed no increased signs of cardiac complications compared to young people who...
View ArticleIntriguing insights uncovered for two rare heart muscle diseases
Researchers at Penn have made advancements in the study of two rare heart conditions—peripartum cardiomyopathy (PPCM), and dilated cardiomyopathy (DCM)
View ArticleUPHS and Doylestown Health Sign Letter of Intent for Integration
The University of Pennsylvania Health System and Doylestown Health leaders announced plans today for the Bucks County health system to become part of Penn Medicine.
View ArticleAwards & Accolades: December 2023
Learn how Penn clinicians and researchers are being honored by their peers.
View ArticlePenn leads largest-ever study of inpatient palliative care
“Default orders” in the electronic medical record nearly tripled palliative care consultation rates for seriously ill patients in a large community hospital system.
View Article'Exhalation' System Improves Symptoms of Chronic Sinus Infections
An exhalation delivery system that uses a patient’s own breath to carry an anti-inflammatory directly to the sinuses reduced chronic sinus infection symptoms in two Phase III clinical trials.
View ArticleGlaucoma gene variants identified in people of African ancestry
A new analysis focusing specifically on people of African ancestry identified three gene variants that may be contributing to this population’s susceptibility to developing and being blinded by glaucoma.
View ArticleFirst Successful External Liver Perfusion Using a Porcine Liver
A Penn research team announced the first successful completion of an experiment to circulate a recently deceased donor’s blood through a genetically engineered pig liver outside their body.
View ArticleE. John Wherry, PhD, and John M. Maris, MD, named AACR Fellows
Penn Medicine’s E. John Wherry, PhD, and CHOP’s John M. Maris, MD, have been named Fellows of the AACR Academy and will be recognized at the 2024 AACR Annual Meeting.
View ArticleASCI elects new members from Penn, CHOP
The physician-scientists are among 100 active members across 50 institutions elected in 2024.
View ArticleImaging 1 week after immunotherapy can predict melanoma survival
Imaging patients with melanoma after just one week of immunotherapy illuminated metabolic changes in their tumors that corresponded with a response to the treatment and longer survival.
View ArticleSecondary Cancers Following CAR T Cell Therapy Are Rare
The development of any type of second cancer following CAR T cell therapy treatment is a rare occurrence, as found in an analysis of more than 400 patients treated at Penn Medicine, which also details...
View ArticlePenn Medicine CAREs Grant program surpasses $1 million in funding
35 grants awarded this quarter span projects including a youth leadership seminar, therapy dog training and maintaining community gardens.
View ArticleA prescription for improving medical communication
The Penn Medical Communication Research Institute team proposes a communication framework for providers to effectively convey their message to patients and communities across all ages, backgrounds, and...
View Article